HIF1A and pancreatic neoplasm: Of note, free CHC+US treatment showed little impact on tumor growth inhibition, cell damage induction, and HIF‐1α down‐expression (Figure 3i; Figure S32, Supporting Information), which meant that CHC enabled SDT responses only when delivered by our nanoplatform, as free administration of CHC had limited access to the pancreatic tumor site.